Eliana B. Souto

Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery

Eliana B. Souto, S. A. Wissing, Carlos Maurı́cio Barbosa et al. · International Journal of Pharmaceutics · 2004 · 657 citations · Full text

Medicine, Controlled Release Formulation, Topical Drug +5

Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.

Susana Martins, Bruno Sarmento, Domingos Ferreira et al. · PubMed · 2007 · 400 citations

Nanoparticles, Engineering, Lipid Nanoparticles +18

Cetyl palmitate-based NLC for topical delivery of Coenzyme Q10 – Development, physicochemical characterization and in vitro release studies

Veerawat Teeranachaideekul, Eliana B. Souto, Varaporn Buraphacheep Junyaprasert et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2007 · 318 citations

Pharmaceutical Science, Vitro Release Studies, Medicine +7

Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model

Amanda Cano, Miren Ettcheto, Jui-Hsien Chang et al. · Journal of Controlled Release · 2019 · 315 citations · Full text

Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals

Rainer Müller, Stephan Runge, Vitale Ravelli et al. · International Journal of Pharmaceutics · 2006 · 301 citations

Nanoparticles, Nanomedicine, Oral Bioavailability +8